VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $805 | -62.0% | 26,734 | -59.2% | 0.33% | -64.7% |
| Q1 2023 | $2,121 | +5.6% | 65,558 | -6.5% | 0.94% | +29.3% |
| Q4 2022 | $2,009 | -99.9% | 70,115 | +33.4% | 0.73% | +16.9% |
| Q1 2022 | $2,016,000 | +10.5% | 52,560 | -7.7% | 0.62% | +90.5% |
| Q4 2021 | $1,824,000 | +139.4% | 56,952 | +120.2% | 0.33% | +39.1% |
| Q3 2021 | $762,000 | +256.1% | 25,860 | +310.5% | 0.24% | +434.1% |
| Q2 2021 | $214,000 | -93.6% | 6,299 | -93.8% | 0.04% | -94.9% |
| Q1 2021 | $3,319,000 | +40.5% | 102,134 | +55.8% | 0.86% | +51.8% |
| Q4 2020 | $2,362,000 | – | 65,567 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |